Research Tools

For more information on UTMDACC technologies, please contact the Office of Technology Commercialization (713-745-9604).  Please indicate the technology number (MDA#) in your correspondence.

MDA09-061
Rat Monoclonal Antibodies Against Mouse IL-22
Please contact the office for more information on this technology.

MDA09-060
RPPA Data
Please contact the office for more information on this technology.

MDA09-032
Digital Restriction Enzyme Analysis of Methylation (DREAM)
Please contact the office for more information on this technology.

MDA09-031
Dose-response Linearizer of Gene Expression
Please contact the office for more information on this technology.

MDA09-020
Hybridoma Clone for 1A3 Anti-Alix Monoclonal Antibody
Please contact the office for more information on this technology.

MDA09-008
Reverse Phase Protein Arrays (RPPA) of Cell Lines
Please contact the office for more information on this technology.

MDA09-003
Human Mid-Gut Carcinoid Tumor Cell Line-CNDT10.5
Please contact the office for more information on this technology.

MDA09-002
Anti-SIN1 polyclonal antibody
Please contact the office for more information on this technology.

MDA08-152
IL-17F-RFP Reporter/IL-17F-Deficient Mice
Please contact the office for more information on this technology.

MDA08-148
Cell-based Assay to Measure mRNA Translation
Please contact the office for more information on this technology.

MDA08-145
Epithelial-mesenchymal Transition (EMT) Reporter Cell Line
Please contact the office for more information on this technology.

MDA08-121
Immortalized Human Pancreatic Stellate Cells
Please contact the office for more information on this technology.

MDA08-094
Anti-human Thymic Stromal Lymphopoietin Receptor (TSLPR) Antibodies
Please contact the office for more information on this technology.

MDA08-082
Magnetic Guidance Patterning of Cells and Biologically Relevant Chemicals Using Magnetic-Nanoparticle-Loaded Bioinorganic Hydrogels
Please contact the office for more information on this technology.

MDA08-066
MDA-IBC-1
Please contact the office for more information on this technology.

MDA08-053
A Novel Transgenic Murine Model of Obesity: Autotaxin Transgenic Mouse
Please contact the office for more information on this technology.

MDA08-050
Tamoxifen Resistant MCF7 Breast Cancer Line Genetically Modified to Express the Gene CtIP (RBBP8) Under the Control of the Tet-off System
Please contact the office for more information on this technology.

MDA08-019
Active Trypsin
Please contact the office for more information on this technology.

MDA08-001
Regulation of Post-Prandial Glucose by F-BAR Proteins
Please contact the office for more information on this technology.

MDA07-120
Gcn5 hat/hat mouse
Please contact the office for more information on this technology.

MDA07-092
MTA1-dependent Mouse Models of Human Diseases
Please contact the office for more information on this technology.

MDA06-121
A Series of Cell Lines that can be Used to Screen for Factors (Drugs, Molecules, Natural Substances) that Reverse Gene Silencing by DNA Methylation and Histone Deacetylation
Please contact the office for more information on this technology.

MDA06-111
TAP-p53 Mouse and ES Cell Lines
Please contact the office for more information on this technology.

MDA06-108
Anti-DSP Monoclonal Antibody, 2G7.3
Please contact the office for more information on this technology.

MDA06-092
High-Throughput Screening for Inhibitors of Protein-Protein Interactions
Please contact the office for more information on this technology.

MDA06-083
Method of Identifying an Agent that Promotes Generation of New Cardiomyocytes
Please contact the office for more information on this technology.

MDA06-057
Human Mid-Gut Carcinoid Tumor Cell Line
Please contact the office for more information on this technology.

MDA06-014
EWS-FL11 Transgenic Mouse (Lines A, B and C)
Please contact the office for more information on this technology.

MDA06-001
CARM1 Knockout Cell Lines
Please contact the office for more information on this technology.

MDA04-086
Rapid Detection of IgH/BCL2 Rearrangement in Follicular Lymphoma by Interphase Fluorescence In Situ Hybridization with Bacterial Artificial Chromosome Probes
Please contact the office for more information on this technology.

MDA04-055
A Series of Novel Retrovirus-Based, Molecular Two-Hybrid Screens (ReMTH) for Protein-Protein Interactions in Mammalian Cells
WO/2006/017279

MDA04-001
Antibody Specific for Histone Acetylated at Lysines 9 and/or 18
Please contact the office for more information on this technology.

MDA02-051
Col2a1-Directed Expression of Cre Recombinase in Differentiating Chondrocytes in Transgenic Mice
Please contact the office for more information on this technology.

MDA02-040
Osteocalcin Promoter Plasmid
Please contact the office for more information on this technology.

MDA02-007
Adenoviral Vectors Expressing the Bax Gene from Tumor- or Cell-Type Specific Promoter and Methods of Use Thereof
Please contact the office for more information on this technology.

MDA99-066
Development of an Animal Model for Disseminated Human Lung Tumors
Please contact the office for more information on this technology.

MDA98-023
Mouse Model of Inducible and Reversible Osteoporosis
Please contact the office for more information on this technology.

MDA97-007
Human Prostate Cancer Cell Lines MDA Pca 2a and MDA Pca 2b
Please contact the office for more information on this technology.

MDA95-059
The sm22a Gene Control Region as a Smooth Muscle Cell-Specific Regulatory Cassette for Gene Therapy
5,837,534
6,015,711

MDA94-028
MPM2 - A Monoclonal Antibody Preferentially Recognizing Miotic Cells of a Variety of Species
Please contact the office for more information on this technology.

MDA92-010
p53 Plasmids
Please contact the office for more information on this technology.